zirconium has been researched along with sirolimus in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Jong, S; de Vries, EG; Kosterink, JG; Lub-de Hooge, MN; Pot, L; Reyners, AK; Schröder, CP; Terwisscha van Scheltinga, AG; Timmer-Bosscha, H; van der Bilt, AR; van der Zee, AG | 1 |
| Dobrzynski, P; Janeczek, H; Jarzabek, B; Jelonek, K; Kasperczyk, J; Li, S | 1 |
| Bongaerts, AH; Brouwers, AH; de Jong, JR; de Vries, EG; Fiebrich, HB; Links, TP; Lub-de Hooge, MN; Oosting, SF; Oude Munnink, TH; Sluiter, WJ; van Asselt, SJ; Walenkamp, AM | 1 |
| Chen, C; Dai, D; Niu, J; Pei, J; Shi, Y; Yuan, G; Zhang, R; Zhang, X; Zhu, J; Zhu, Z | 1 |
4 other study(ies) available for zirconium and sirolimus
| Article | Year |
|---|---|
Measurement of tumor VEGF-A levels with 89Zr-bevacizumab PET as an early biomarker for the antiangiogenic effect of everolimus treatment in an ovarian cancer xenograft model.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal, Humanized; Bevacizumab; Biomarkers, Tumor; Cell Line, Tumor; Everolimus; Female; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Ovarian Neoplasms; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals; Sirolimus; TOR Serine-Threonine Kinases; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays; Zirconium | 2012 |
Novel poly(L-lactide-co-ε-caprolactone) matrices obtained with the use of Zr[Acac]₄ as nontoxic initiator for long-term release of immunosuppressive drugs.
Topics: Cyclosporine; Delayed-Action Preparations; Hydroxybutyrates; Immunosuppressive Agents; Pentanones; Polyesters; Sirolimus; Zirconium | 2013 |
Everolimus Reduces (89)Zr-Bevacizumab Tumor Uptake in Patients with Neuroendocrine Tumors.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Bevacizumab; Biological Transport; Chromogranin A; Everolimus; Feasibility Studies; Female; Humans; Male; Middle Aged; Neuroendocrine Tumors; Positron-Emission Tomography; Radioisotopes; Sirolimus; Treatment Outcome; Vascular Endothelial Growth Factor A; Zirconium | 2014 |
Biosafety and efficacy evaluation of a biodegradable magnesium-based drug-eluting stent in porcine coronary artery.
Topics: Alloys; Animals; Aorta, Thoracic; Cell Adhesion; Containment of Biohazards; Coronary Angiography; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Magnesium; Microscopy, Electron, Scanning; Myocytes, Smooth Muscle; Neodymium; Patient Safety; Percutaneous Coronary Intervention; Polyesters; Rats; Sirolimus; Stress, Mechanical; Swine; Tomography, Optical Coherence; X-Ray Microtomography; Zinc; Zirconium | 2021 |